We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
51 hedge funds and large institutions have $134M invested in Regulus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
91% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 11
59% more capital invested
Capital invested by funds: $84M → $134M (+$49.9M)
31% more funds holding
Funds holding: 39 → 51 (+12)
Holders
51
Holders Change
+12
Holders Change %
+30.77%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
21
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.8M |
| 2 |
HM
HealthCor Management
New York
|
+$9.59M |
| 3 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$8.85M |
| 4 |
Jennison Associates
New York
|
+$3.52M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.62M |
Top Sellers
| 1 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$2.4M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.35M |
| 3 |
Morgan Stanley
New York
|
-$393K |
| 4 |
SIM
Spark Investment Management
New York
|
-$347K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$322K |
